Document Detail

Pulmonary artery pressure, gender, menopause, and pregnancy in schistosomiasis-associated pulmonary hypertension.
Jump to Full Text
MedLine Citation:
PMID:  23821406     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Schistosomiasis-associated pulmonary arterial hypertension (SPAH) is a major concern worldwide. However, the role of gender-specific contributing factors in SPAH is unknown.
OBJECTIVE: We investigated how systolic pulmonary artery pressure (SPAP) values and the presence of severe SPAP relate to gender, menopausal status, and pregnancy history in SPAH patients.
METHODS: Seventy-nine patients diagnosed with SPAH from 2000 to 2009 were assessed and 66 were enrolled in the study. Information about age, menopausal status, pregnancy, echocardiography-derived SPAP, and invasive mean pulmonary artery pressure (mPAP) was collected from medical records. The relation between values of SPAP and mPAP and their agreement for severe disease were assessed. Regression models assessed the association of gender, menopausal status, and pregnancy history with SPAP values and the presence of severe SPAP.
RESULTS: Moderate correlation and good agreement for severe disease were found between mPAP and SPAP. Mean SPAP values were similar for men and women. A trend toward higher values of SPAP was found for non-menopausal women compared to men. Higher SPAP values were found for menopausal compared to non-menopausal women; the values were non-significant after adjustment for age. Pregnancy history had no association with SPAP. Menopause and positive pregnancy had no association with severe SPAP.
CONCLUSION: In SPAH patients, neither gender, nor menopausal status, nor pregnancy history showed independent correlation with SPAP values assessed by echocardiography.
Authors:
Anderson C Armstrong; Ângela M P Bandeira; Luis C L Correia; Humberto C O Melo; Carlos A M Silveira; Eugênio Albuquerque; Jeová C Moraes; Antônio M L Silva; João A C Lima; Dário C Sobral Filho
Related Documents :
14551026 - Acog committee opinion number 288, october 2003: professional liability and gynecology-...
65336 - Sequential release of histamine and 5-hydroxytryptamine during pinnal anaphylaxis in th...
21077156 - Clinical implications of intra- and inter-observer reproducibility of first trimester m...
18239006 - Transient severe fetal heart rate abnormalities in a pregnancy complicated by thromboti...
7485286 - Delivery of the nonvertex second twin: breech extraction versus external cephalic version.
10608766 - Repeated pregnancies in balb/c mice infected with coxiella burnetii cause disseminated ...
Publication Detail:
Type:  Journal Article     Date:  2013-07-02
Journal Detail:
Title:  Arquivos brasileiros de cardiologia     Volume:  101     ISSN:  1678-4170     ISO Abbreviation:  Arq. Bras. Cardiol.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-09-13     Completed Date:  2014-03-14     Revised Date:  2014-05-11    
Medline Journal Info:
Nlm Unique ID:  0421031     Medline TA:  Arq Bras Cardiol     Country:  Brazil    
Other Details:
Languages:  eng; por     Pagination:  154-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Arterial Pressure / physiology*
Echocardiography, Doppler
Female
Humans
Hypertension, Pulmonary / etiology*,  physiopathology
Male
Menopause / physiology*
Middle Aged
Pregnancy
Pulmonary Artery / physiopathology
Reference Values
Reproductive History
Schistosomiasis / complications*,  physiopathology
Severity of Illness Index
Sex Factors
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Arq Bras Cardiol
Journal ID (iso-abbrev): Arq. Bras. Cardiol
Journal ID (publisher-id): Arq. Bras. Cardiol.
ISSN: 0066-782X
ISSN: 1678-4170
Publisher: Sociedade Brasileira de Cardiologia
Article Information
Download PDF

open-access:
Received Day: 26 Month: 10 Year: 2012
Revision Received Day: 19 Month: 11 Year: 2012
Accepted Day: 06 Month: 3 Year: 2013
Print publication date: Month: 8 Year: 2013
Volume: 101 Issue: 2
First Page: 154 Last Page: 159
PubMed Id: 23821406
ID: 3998155
DOI: 10.5935/abc.20130130

Pulmonary Artery Pressure, Gender, Menopause, and Pregnancy in Schistosomiasis-Associated Pulmonary Hypertension
Anderson C. Armstrong123
Ângela M. P. Bandeira2
Luis C. L. Correia4
Humberto C. O. Melo2
Carlos A. M. Silveira2
Eugênio Albuquerque2
Jeová C. Moraes, Jr.3
Antônio M. L. Silva3
João A. C. Lima1
Dário C. Sobral, Filho2
1Escola de Medicina Johns Hopkins - Divisão de Cardiologia, Baltimore, MD
2Universidade de Pernambuco – Faculdade de Ciências Médicas, Recife, PE - Brazil
3Universidade Federal do Vale do São Francisco - Colegiado de Medicina, Petrolina, PE - Brazil
4Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brazil
Correspondence: Mailing Address: Anderson C. Armstrong, 600 North Wolfe Street / Blalock 524. Baltimore, MD 21287-0409, USA. E-mail: aarmst10@jhmi.edu

Introduction

Schistosomiasis affects about 207 million people worldwide and is known as a potential trigger for the pulmonary arterial hypertension (PAH) immune-inflammatory pathway. Schistosomiasis-associated PAH (SPAH) is recognized as one of the most important etiologies of PAH - with a prevalence of approximately 5% in patients with hepatosplenic schistosomiasis. PAH is a high-risk condition, related to elevated rates of mortality1-6. However, literature regarding the clinical presentation of SPAH is limited.

Echocardiography-derived systolic pulmonary artery pressure (SPAP) is usually used to screen patients suspected of PAH. Adding right atrial pressure to the pressure gradient between right atrium and ventricle has been validated as a method to assess SPAP over the decades7,8. In fact, SPAP assessed by Doppler-echocardiography is a well-established method in clinical practice, being widely available, inexpensive, and safe9-15.

In PAH clinical presentation, the role of gender-specific characteristics is controversial. Despite the evidence that female hormonal balance could be related to pulmonary artery pressure, studies have failed to demonstrate significant differences in the prognosis of PAH in men compared to women16-18. Moreover, the interest in menopausal aspects of PAH is growing, as postmenopausal women have shown significant susceptibility to elevated pulmonary pressure19,20.

We investigated how SPAP values and severity relate to gender in patients with SPAH. We also explored the association of SPAP with menopausal status and pregnancy history in the female population. Finally, we compared echocardiography-derived SPAP values to values of invasive mean pulmonary artery pressure (mPAP).


Methods
Study design and population

We enrolled 89 patients (67% women) who had been diagnosed with SPAH by the Pulmonary Hypertension Group at University of Pernambuco (Recife, Brazil) between January 2000 and November 2009. Investigation for PAH follows the protocol suggested by Gaine and Rubin, including diagnostic right-chamber catheterization to ensure values of mPAP > 25 mmHg and pulmonary capillary wedge pressure (PCWP) <15 mmHg21. The diagnosis of schistosomiasis is individually assessed and based on exposure history and stool samples, with confirmatory rectal biopsy and/or serology in specific cases22. In the absence of other etiology, SPAH was defined when schistosomiasis and portal fibrosis were present in a patient with PAH assessed by invasive right-chamber catheterization. Our study was approved by the local ethics committee.

SPAP assessment

SPAP data were collected from the first registered echocardiogram performed and interpreted by staff cardiologists at the institution of enrolment. Suboptimal echocardiogram views or inadequate tricuspid regurgitation were present in 4 men and 9 women. The institution's protocol to assess SPAP dictates the following: (a) patient in the left lateral decubitus position; (b) color flow Doppler imaging is used to identify and guide alignment of the cursor with the tricuspid regurgitant jet; (c) using continuous-wave Doppler, tricuspid regurgitation velocity is assessed from different views to measure peak velocity (v); (d) transtricuspid pressure gradient is calculated using the modified Bernoulli equation (4v2) 7; (e) right atrial pressure is evaluated by assessing the respiratory variation in the diameter of the inferior vena cava (values estimated as 5, 10, or 15 mmHg); and (f) SPAP is calculated by adding the transtricuspid pressure gradient to the atrial pressure estimate. The measurement is not performed if there is evidence of obstruction to pulmonary artery flow, such as pulmonary stenosis or right ventricular outflow obstruction.

Additional data acquisition

Information on age, menopausal status, and pregnancy history at the diagnosis of SPAH was collected from medical records on all patients followed in the institution. Information on menopausal status was present in 35 women (58% menopause positive) and data on pregnancy history was collected in 20 women (13 had positive history for pregnancy; 56% vs. 73% for non-menopausal vs. menopausal women, respectively). Invasive mean pulmonary artery pressure (mPAP), assessed by diagnostic right-chamber catheterization, was also collected if the interval to the assessment of echocardiography-derived SPAP did not exceed 6 months (n = 42; 81% females; age 44.5 ± 14.3 years; SPAP 96.7 ± 28.8 mmHg; and mPAP 60.3 ± 14.7 mmHg).

Statistical analysis

The software STATA, version 11.2, was used to perform the statistical analysis on a cross-sectional basis. Student's t-test was used to assess differences between mean values and the z-test was used to assess differences between proportions. Severe SPAP and mPAP were defined as the 4th quartile in both cases (≥ 120 mmHg and ≥ 76 mmHg for SPAP and mPAP, respectively). The relationship between echocardiography-derived SPAP and invasive mPAP was assessed by Pearson's correlation. Percent agreement and Cohen's kappa coefficient for severe classification of SPAP and mPAP were also computed.

The relation of SPAP, gender, and menopausal status was assessed using linear regression. Logistic regression was used to compute odds ratios for severe SPAP, according to gender and menopausal status. Regression models were performed on univariate and multivariate bases, adjusted to age at diagnosis. Menopausal status as a predictor of SPAP values was compared to male gender and as a binary variable in a female-only subset. For a subgroup of women diagnosed with SPAH, an additional analysis assessed the influence of pregnancy history (used as a binary variable) in the regression models.


Results

A total of 66 patients with data on SPAP were included. Patient characteristics are shown in Table 1, arranged according to gender and menopausal status. A moderate correlation was found between mPAP and SPAP (r = 0.51, p < 0.001; Figure 1). In this group, both methods classified 10 cases as severe SPAH, agreeing in 82% of the classifications (Kappa coefficient = 0.3; p < 0.01). Mean SPAP values were similar for men and women (Table 1). In addition, no significant difference was found when menopausal women were compared to men. However, higher values of SPAP were found for non-menopausal women compared to men, with a trend in significance (Table 2).

Among females, statistically significant higher mean SPAP values and ages were found for menopausal women (Table 1). However, the differences become non-significant after adjustment for age. The mean SPAP was 118.3 ± 32.3 mmHg and 95.1 ± 26.2 mmHg (p = 0.1) for women without and with previous pregnancy, respectively. No statistical significance was found when history of pregnancies was added as a covariate (Table 2).

Considering the prediction of severe SPAH (SPAP > 120 mmHg), the presence of menopause and a positive history for pregnancy were consistently associated with low odds ratios; however, although trends were present, no statistically significant odds ratio was reported (Table 3).


Discussion

More than 770 million people worldwide are at risk of contracting schistosomiasis2,23. The prevalence of elevated pulmonary pressures in patients with schistosomiasis is still controversial, but it has been reported as one of the most important etiologies of PAH1-5,24,25. This is the first study to assess the influence of gender on echocardiography-derived SPAP and to investigate the role of menopausal status and pregnancy history among patients diagnosed with SPAH.

The estimation of SPAP by Doppler echocardiography is validated, safe, usually feasible, and universally adopted in screening protocols for PAH8,26-28. We showed a moderate correlation between echocardiography-derived SPAP and invasive measurement of mPAP in patients with SPAH (Figure 1), with 82% of agreement and a fair Kappa coefficient when classifying the most severe cases. mPAP values assessed by right-chamber catheterization are considered the gold standard for the diagnosis of PAH. Similar to our study, diverse reports have shown that the correlation between SPAP values estimated by echocardiography and determined invasively is moderate to strong7,11,12,29,30.

We found a predominance of females in our SPAH patients (67%). A similar predominance of females has been reported for other PAH etiologies, but the real influence of gender in PAH is still controversial. The higher prevalence of PAH in women compared to men, the thrombogenic effects of estrogen, and the fluctuation of estrogen metabolites may indicate potential negative effects of female physiology on the pulmonary vasculature31,32. Estrogen, however, also showed benefits for pulmonary vasculature in both acute and chronic experimental models of pulmonary hypertension31,32. We found similar values of SPAP in men and women with SPAH. Moreover, gender had no statistically significant predictive ability for SPAP when adjusted for age at diagnosis (Table 2).

Pulmonary artery vasoreactivity is affected by changes in estrogen levels, even in a physiological range33. Menopausal status represents an important decrease in the circulating estrogen in women. Among patients with systemic sclerosis, postmenopausal women have shown an increased risk for the development of PAH19. In fact, the majority of pulmonary hypertensive women in the University of Colorado Pulmonary Hypertension Center were postmenopausal20. Our study has intrinsic limitations related to the information on menopausal status collected from medical records. In addition, the real influence of hormonal imbalance could not be assessed, due to the absence of serum hormonal values in our data.

In the subset of SPAH patients who were women, the association between menopausal status and SPAP had no statistical significance when adjusted for age (Table 2). In univariate analysis with SPAH patients, non-menopausal females showed significantly higher SPAP values compared to men; however, this association had borderline statistical significance (p = 0.05) after adjustment for age (Table 2). Our results suggest that the differences found comparing post-menopausal and non-menopausal subjects are due to the influence of age on SPAP. In fact, the positive correlation between SPAP values and age has been seen in a large population of participants free of PAH. In this population, the relationship seems to be mediated by left ventricular diastolic dysfunction and systemic vascular stiffening34.

Hormonal and hemodynamic changes that occur during pregnancy contribute to the high maternal mortality in women with pulmonary vascular disease35. The influence of previous pregnancies on the clinical presentation of SPAH, however, is unknown. In 20 women at the time of diagnosis for SPAH, we assessed the influence of a positive pregnancy history on the values of SPAP. Thus, the reduced number of patients probably limited the analysis. In our population, positive pregnancy history did not show statistically significant association with SPAP in women with SPAH.

There is evidence that female hormonal imbalance may relate to the severity of pulmonary pressure values. Experimental models showed more severe pulmonary hypertension in chronically hypoxemic rodents that have had their ovaries removed than those with intact ovaries. In this study, the return of estrogens after an ovariectomy led to a regression to baseline levels of pulmonary pressure36. Moreover, a history of previous pregnancies showed prognostic value in pregnant patients with pulmonary hypertension37. We investigated how gender, menopausal status, and pregnancy history predicted severe SPAP values (> 120 mmHg) in SPAH patients, but found no statistically significant association (Table 3).

Our study contributes to the knowledge of SPAH clinical presentation and its relation to gender, menopausal status, and pregnancy history; however, the role of gender-specific characteristics in the pathological processes of SPAH is yet to be defined. Further studies are needed to establish the relations between gender particularities and SPAH clinical presentation.


Conclusion

In a population of SPAH patients, neither gender, nor menopausal status, nor pregnancy history showed a statistically significant, independent relationship to SPAP values assessed by echocardiography. Differences in SPAP that appear to be related to menopausal status seem to be mediated by age differences.


Author contributions

Conception and design of the research: Armstrong AC, Bandeira AMP, Correia LCL, Lima JAC, Sobral Filho DC; Acquisition of data: Armstrong AC, Bandeira AMP, Melo HCO, Silveira CAM, Albuquerque E, Moraes Jr. JC, Silva AML, Sobral Filho DC; Analysis and interpretation of the data: Armstrong AC, Bandeira AMP, Correia LCL, Melo HCO, Silveira CAM, Albuquerque E, Moraes Jr. JC, Silva AML, Lima JAC, Sobral Filho DC; Statistical analysis: Armstrong AC, Bandeira AMP, Correia LCL, Sobral Filho DC; Writing of the manuscript: Armstrong AC, Lima JAC, Sobral Filho DC; Critical revision of the manuscript for intellectual content: Armstrong AC, Bandeira AMP, Correia LC, Melo HCO, Silveira CAM, Albuquerque E, Moraes Jr. JC, Silva AML, Lima JAC, Sobral Filho DC.


Notes

fn01Potential Conflict of Interest: No potential conflict of interest relevant to this article was reported.

fn02Sources of Funding: There were no external funding sources for this study.

fn03Study Association: This article is part of the thesis of master submitted by Anderson da Costa Armstrong, from Universidade de Pernambuco.

Acronym and abbreviation listmPAP - mean pulmonary artery pressure

PAH - pulmonary arterial hypertension

SPAP - pulmonary artery systolic pressure

SPAH - schistosomiasis-associated pulmonary arterial hypertension

References
1. Ross AG,Bartley PB,Sleigh AC,Olds GR,Li Y,Williams GM,et al. SchistosomiasisN Engl J MedYear: 2002346161212122011961151
2. Steinmann P,Keiser J,Bos R,Tanner M,Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskLancet Infect DisYear: 20066741142516790382
3. Ferreira RC,Domingues AL,Bandeira AP,Markman B Filho,Albuqerque ES Filho,Correia deAraujo AC,et al. Prevalence of pulmonary hypertension in patients with schistosomal liver fibrosisAnn Trop Med ParasitolYear: 2009103212914319208297
4. Souza R,Fernandes CJ,Jardim CV. Other causes of pah (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension)Semin Respir Crit Care MedYear: 200930444845719634084
5. Lapa M,Dias B,Jardim C,Fernandes CJ,Dourado PM,Figueiredo M,et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasisCirculationYear: 2009119111518152319273723
6. Fernandes CJ,Jardim CV,Hovnanian A,Hoette S,Morinaga LK,Souza R. Schistosomiasis and pulmonary hypertensionExpert Rev Respir MedYear: 20115567568121955237
7. Yock PG,Popp RL. Noninvasive estimation of right ventricular systolic pressure by doppler ultrasound in patients with tricuspid regurgitationCirculationYear: 19847046576626478568
8. Ristow B,Schiller NB. Stepping away from ritual right heart catheterization into the era of noninvasively measured pulmonary artery pressureJ Am Soc EchocardiogrYear: 200922782082219560660
9. Callou MR,Ramos PR. Hipertensão arterial pulmonarArq Bras CardiolYear: 2009935Suppl 1156159
10. Badano LP,Ginghina C,Easaw J,Muraru D,Grillo MT,Lancellotti P,et al. Rightventricle in pulmonary arterial hypertension: haemodynamics, structuralchanges, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effectsEur J EchocardiogrYear: 2010111273719815539
11. Testani JM,St John Sutton MG,Wiegers SE,Khera AV,Shannon RP,Kirkpatrick JN. Accuracy of noninvasively determined pulmonary artery systolic pressureAm J CardiolYear: 201010581192119720381676
12. Shapiro SM,Oudiz RJ,Cao T,Romano MA,Beckmann XJ,Georgiou D,et al. Primary pulmonary hypertension: improvedlong-termeffectsand survival with continuous intravenous epoprostenol infusionJ Am Coll CardiolYear: 19973023433499247503
13. Fisher MR,Criner GJ,Fishman AP,Hassoun PM,Minai OA,Scharf SM,et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysemaEur Respir JYear: 200730591492117652313
14. Chemla D,de Zuttere D,Herve P. Echocardiographic evaluation of systolic and mean pulmonary artery pressure in patients with pulmonary hypertensionEur J EchocardiogrYear: 2011121296996922109248
15. Pyxaras SA,Pinamonti B,Barbati G,Santangelo S,Valentincic M,Cettolo F,et al. Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertensionEur J EchocardiogrYear: 201112969670121821609
16. D'Alonzo GE,Barst RJ,Ayres SM,Bergofsky EH,Brundage BH,Detre KM,et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registryAnn Intern MedYear: 199111553433491863023
17. Rich S,Dantzker DR,Ayres SM,Bergofsky EH,Brundage BH,Detre KM,et al. Primary pulmonary hypertension: A national prospective studyAnn Intern MedYear: 198710722162233605900
18. Humbert M,Sitbon O,Chaouat A,Bertocchi M,Habib G,Gressin V,et al. Pulmonary arterial hypertension in france: Results from a national registryAm J Respir Crit Care MedYear: 200617391023103016456139
19. Scorza R,Caronni M,Bazzi S,Nador F,Beretta L,Antonioli R,et al. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosisAnn N Y Acad SciYear: 200296623824612114278
20. Taraseviciute A,Voelkel NF. Severe pulmonary hypertension in postmenopausal obese womenEur J Med ResYear: 200611519820216723293
21. Gaine SP,Rubin LJ. Primary pulmonary hypertensionLancetYear: 199835292297197259729004
22. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção BásicaVigilância em saúde: dengue, esquistossomose, hanseníase, malária, tracoma, tuberculoseBrasíliaYear: 2007 (Cadernos de Atenção Básica nº 21. Série A. Normas e Manuais Técnicos).
23. Graham BB,Bandeira AP,Morrell NW,Butrous G,Tuder RM. Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspectiveChestYear: 20101376Suppl20S29S20522577
24. Lopes AA,Bandeira AP,Flores PC,Santana MV. Pulmonary hypertension in latinamerica: pulmonary vascular disease: the global perspectiveChestYear: 20101376Suppl78S84S20522583
25. Machado C,Brito I,Souza D,Correia LC. Etiological frequency of pulmonary hypertension in a reference outpatientclinic in Bahia, BrazilArq Bras CardiolYear: 2009936629686629-36, 679-8620379644
26. Currie PJ,Seward JB,Chan KL,Fyfe DA,Hagler DJ,Mair DD,et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patientsJ Am Coll CardiolYear: 1985647507564031289
27. Berger M,Haimowitz A,Van Tosh A,Berdoff RL,Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave doppler ultrasoundJ Am Coll CardiolYear: 1985623593654019921
28. Lopez-Candales A,Edelman K. Shape of the right ventricular outflow doppler envelope and severity of pulmonary hypertensionEur Heart J Cardiovasc ImagingYear: 201213430931622087011
29. Kuppahally SS,Michaels AD,Tandar A,Gilbert EM,Litwin SE,Bader FM. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?Am J CardiolYear: 2010106111657166221094370
30. Tramarin R,Torbicki A,Marchandise B,Laaban JP,Morpurgo M. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Groupon Non invasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, CopenhagenEur Heart JYear: 19911221031112044542
31. Lahm T,Crisostomo PR,Markel TA,Wang M,Weil BR,Novotny NM,et al. The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction. potential new clinical implications for an old hormoneCrit Care MedYear: 20083672174218318552699
32. Pugh ME,Hemnes AR. Development of pulmonary arterial hypertension in women. Interplay of sex hormones and pulmonary vascular diseaseWomens Health (Lond Engl)Year: 20106228529620187732
33. Lahm T,Patel KM,Crisostomo PR,Markel TA,Wang M,Herring C,et al. Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycleAm J Physiol Endocrinol MetabYear: 20072933E865E87117595218
34. Lam CS,Borlaug BA,Kane GC,Enders FT,Rodeheffer RJ,Redfield MM. Age-associated increases in pulmonary artery systolic pressure in the general populationCirculationYear: 2009119202663267019433755
35. Warnes CA. Pregnancy and pulmonary hypertensionInt J CardiolYear: 200497Suppl 1111315590074
36. Resta TC,Kanagy NL,Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered enos expressionAm J Physiol Lung Cell Mol PhysiolYear: 20012801L88L9711133498
37. Weiss BM,Zemp L,Seifert B,Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996J Am Coll CardiolYear: 1998317165016579626847

Figures

[Figure ID: f01]
Figure 1 

Scatter plot for the correlation between echocardiography-derived SPAP and invasive mPAP in patients with schistosomiasis-associated pulmonary hypertension (n = 42). SPAP: Systolic pulmonary artery pressure by echocardiography; mPAP: mean pulmonary artery pressure by invasive measurement.



Tables
[TableWrap ID: t01] Table 1 

Characteristics of patients with schistosomiasis-associated pulmonary hypertension, arranged according to gender and menopausal status


Variable Gender (mean ± SD)   Menopausal status (mean ± SD)
Men (n = 15) Women (n = 51) p   Absent (n = 15) Present (n = 20) p
Age at diagnosis (years) 46.8 ± 12.8 45.9 ± 15.1 0.8   29.4 ± 6.8 58.4 ± 9.8 < 0.0001
SPAP (mmHg) 87.8 ± 31.6 93.8 ± 28.3 0.5   110.7 ± 26.0 86.5 ± 20.0 0.003
Number of pregnancies NA 3.2 ± 2.8 NA   1.6 ± 0.5 4.2 ± 3.2 0.098

SD: standard deviation; SPAP: systolic pulmonary artery pressure; NA: non-applicable. Mean number of pregnancies excludes patients without history of pregnancy (7 cases overall; 2 with positive menopausal status). T-test was used to acquire p-values.


[TableWrap ID: t02] Table 2 

Linear regression models for SPAP (mmHg) according to gender, menopausal status, and pregnancy history


Predictor n Regression coefficients (p value)
Univariate MODEL 1 MODEL 2
Female (vs. male) 66 6.0 (0.48) 13.7 (0.09) NA
non-menopausal women (vs. male) 51 22.9 (0.02) 23.4 (0.05)
Menopausal women (vs. male) 51 -1.3 (0.88) 5.4 (0.59)
Menopausal present (vs. absent)α 36 -24.2 (0.003) -8.4 (0.58) -38.7 (0.11)
Pregnancy present (vs. absent) 20 -23.1 (0.10) -13.9 (0.31) -20.1 (0.15)

SPAP: systolic pulmonary artery pressure; NA: non-applicable. MODEL 1 – adjusted for age; MODEL 2 – age, menopausal status, and pregnancy history in the same model. α In MODEL 2, analysis used n = 20.


[TableWrap ID: t03] Table 3 

Logistic regression models for severe SPAP (≥ 120 mmHg) according to gender, menopausal status, and pregnancy history


Predictor n Odds Ratio (p value)
Univariate MODEL 1 MODEL 2
Female (vs. male) 66 1.2 (0.77) 1.7 (0.51) NA
non-menopausal women (vs. male) 51 2.0 (0.41) 5.5 (0.19)
Menopausal women (vs. male) 51 0.4 (0.38) 0.4 (0.39)
Menopausal present (vs. absent)α 36 0.2 (0.09) 0.4 (0.62) 0.03 (0.14)
Pregnancy present (vs. absent) 20 0.2 (0.14) 0.3 (0.27) 0.1 (0.13)

SPAP: systolic pulmonary arterial pressure; NA: non-applicable. MODEL 1 – adjusted for age; MODEL 2 – age, menopausal status, and pregnancy history in the same model. α In MODEL 2, analysis used n = 20.



Article Categories:
  • Original Article

Keywords: Hypertension, Pulmonary, Schistosomiasis, Pregnancy, Menopause, Echocardiography, Doppler.

Previous Document:  Inappropriate shocks in patients with ICDs: single chamber versus dual chamber.
Next Document:  Angioplasty guided by intravascular ultrasound: meta-analysis of randomized clinical trials.